ProductsAbout usCareersPressBlogLoginRequest a demo
ProductsAbout usCareersPressBlogLoginRequest a demo

Featured

Arbolus: Changing the Expert Network Industry with Generative AI and ArbolusCanopy

Our innovative platform, ArbolusCanopy, is changing the way our investment and consulting clients gather information.

Arbolus: Changing the Expert Network Industry with Generative AI and ArbolusCanopy
Generative AI Unpacked - Your Questions Answered

Webinars

3 min read

Generative AI Unpacked - Your Questions Answered

Audience questions from our recent webinar answered by our experts through ArbolusCanopy.

Generative AI Unpacked - Key insights from the webinar

Webinars

3 min read

Generative AI Unpacked - Key insights from the webinar

Check out some key insights from our recent webinar on generative AI for Businesses and Investors

Arbolus: Changing the Expert Network Industry with Generative AI and ArbolusCanopy

Arbolus Journey

4 min read

Arbolus: Changing the Expert Network Industry with Generative AI and ArbolusCanopy

Our innovative platform, ArbolusCanopy, is changing the way our investment and consulting clients gather information.

Live Webinar: Generative AI Unpacked: Navigating the Hype for Businesses and Investors

Webinars

1 min read

Live Webinar: Generative AI Unpacked: Navigating the Hype for Businesses and Investors

Join us on Tuesday, 18th of April, for an insightful session with experts from Microsoft, Google and PwC.

Arbolus Product Update - March 2023

Platform Releases

3 min read

Arbolus Product Update - March 2023

The latest Arbolus features, updates and UI improvements designed to enhance your Arbolus platform experience.

How ArbolusCanopy fast-tracked market research for a growing HealthTech

Success Stories

2 min read

How ArbolusCanopy fast-tracked market research for a growing HealthTech

Check out how ArbolusCanopy allowed the client to confidently validate their product positioning, without spending hours on interviews.

How Arbolus streamlined a complex Pharma study with tailored solutions

Success Stories

3 min read

How Arbolus streamlined a complex Pharma study with tailored solutions

How Arbolus supported an extensive study on the clinical service & biopharma commercialization space in the US with bespoke solutions.

How ArbolusChannels enriched a vendor DD process with more expert insights

Success Stories

2 min read

How ArbolusChannels enriched a vendor DD process with more expert insights

Channels helped the Big 4 client to collect and analyze additional qualitative data fast without disrupting the case flow.

The Impact of AI and Blockchain Technology on Clinical Trials

Expert Insights

3 min read

The Impact of AI and Blockchain Technology on Clinical Trials

We asked a curated panel of top experts on ArbolusChannels how AI and blockchain technologies will impact the industry.

Arbolus ranked in the top 25 in the FT 1000 Fastest Growing European Companies report 2023

Arbolus Journey

1 min read

Arbolus ranked in the top 25 in the FT 1000 Fastest Growing European Companies report 2023

With revenue growth of over 4000%, Arbolus confidently secured 23rd place on the ranking, in the report by Statista and Financial Times.

Key Insights from the webinar "3 Major Disruptions to Clinical Trials"

Expert Insights

5 min read

Key Insights from the webinar "3 Major Disruptions to Clinical Trials"

Key ideas and insights on major disruptions to Clinical trials discussed during our recent webinar with Chris Baker and Jon Shephard.

Attributable results from niche populations with Arbolus Surveys

Success Stories

2 min read

Attributable results from niche populations with Arbolus Surveys

Find out how Arbolus ensured the success of the client survey in EdTech space.

How ArbolusCanopy accelerated decision-making for a leading VC

Success Stories

2 min read

How ArbolusCanopy accelerated decision-making for a leading VC

Check out how ArbolusCanopy helped a renowned VC firm to quickly test their hypothesis early in their due diligence process.

70% faster research process with ArbolusCanopy

Success Stories

2 min read

70% faster research process with ArbolusCanopy

How Canopy helped a leading private equity firm to gather critical insights faster.

On-demand Webinar: 3 Major Disruptions to Clinical Trials in 2023

Webinars

1 min read

On-demand Webinar: 3 Major Disruptions to Clinical Trials in 2023

Watch our on-demand webinar with Chris Baker, President at ICON, Symphony Health and Jon Shephard, a Partner at PwC.

How ArbolusCanopy reduced project turnaround by 80%

Success Stories

2 min read

How ArbolusCanopy reduced project turnaround by 80%

ArbolusCanopy enabled a Big 4 Consulting client to gather all required insights without conducting any calls.

The North Star Metric: A Product Tale

Growth Matters

3 Min read

The North Star Metric: A Product Tale

The importance and the challenges for companies to define a path towards product-led sustainable business results and customer value.

Ditching paper in healthcare: intelligent operations

Success Stories

4 min read

Ditching paper in healthcare: intelligent operations

As we transition to a paperless future, we look at how the adoption of digital processes is transforming healthcare operations.

The Turning Point: E-commerce & Covid

Expert Insights

4 min read

The Turning Point: E-commerce & Covid

How has the pandemic affected retail and how to thrive in an online marketplace: Head of E-commerce at Amazon.

CannaTech: how are data & technology changing the legal cannabis industry?

Expert Insights

3 min read

CannaTech: how are data & technology changing the legal cannabis industry?

How can data and technology play a role in establishing the safety, efficiency and legitimacy of the legal cannabis industry?

Next

Company

About usCareersPress

Use Cases

For businessesFor professionals

Resources

BlogHelpContact us

Collective IQ Group Ltd

Privacy & CookiesTerms of useInformation security



Products

ArbolusChannelsArbolusCanopyArbolusCalls

Copyright © 2023. All rights reserved.

Arbolus is owned by Collective IQ Group Ltd.